Table 1.
Demographic data (for a subset of 49 patients where such information was available).
| Age (years) | Sex | Years of seizure history | Diagnosis | Antiepileptic drugs | Resection location |
|---|---|---|---|---|---|
| 39 | F | 11 | Tumor | LSC, LRZ, LEV | Right ATL |
| 58 | F | 8 | Tumor | CBZ | Left FL |
| 57 | M | 45 | Epilepsy | LSC, CZP, CBZ | Right ATL |
| 27 | M | 11 | Epilepsy | LSC, LRZ, CLB | Right ATL |
| 24 | M | 8 | Epilepsy | LEV, LTG | Right ATL |
| 25 | M | 12 | Epilepsy | CBZ, LSC | Right ATL |
| 33 | F | 4 | Epilepsy | LEV | Left FL |
| 33 | M | 14 | Epilepsy | PHN, LEV | Right FL |
| 22 | M | 6 | Epilepsy | PHN, CBZ, LTG | Left ATL |
| 21 | M | 2 | Epilepsy | DR, CLB, MJ | Left parietal lobe |
| 22 | M | 12 | Epilepsy | PHN, LRZ | Right ATL |
| 23 | F | 23 | Epilepsy | CBZ, LEV, LSC | Right FL |
| 53 | F | 43 | Epilepsy | CBZ, LSC, LEV | Left ATL |
| 37 | F | 2 | Tumor | GPN, LSC, LEV, CLB, LRZ | Right FL |
| 47 | F | 4 | Epilepsy | CBZ, CLB | Left ATL |
| 52 | M | 13 | Epilepsy | CBZ, CLB | Left ATL |
| 50 | F | 26 | Epilepsy | PHN, LTG | Right ATL |
| 36 | F | 34 | Epilepsy | LSC, CBZ | Left ATL |
| 40 | M | 29 | Epilepsy | LEV | Right ATL |
| 25 | F | 10 | Epilepsy | CBZ, LSC, LEV | Right ATL |
| 52 | M | 27 | Epilepsy | LSC, LRZ | Left ATL |
| 21 | M | 11 | Epilepsy | LTG, CBZ | Left ATL |
| 63 | M | 0.1 | Tumor | PHN | Right parietal lobe |
| 42 | M | 22 | Epilepsy | CBZ | Right FL |
| 25 | F | 22 | Epilepsy | LSC, CLB, LTG | Right FL |
| 24 | F | 3 | Tumor | LEV | Left ATL |
| 53 | M | 9 | Epilepsy | LEV | Left ATL |
| 45 | F | 20 | Epilepsy | LTG | Right ATL |
| 26 | F | 25 | Epilepsy | CBZ, CLB, LTG | Right ATL |
| 35 | F | 14 | Epilepsy | LRZ, DR, PHN | Left ATL |
| 24 | M | 6 | Epilepsy | LSC, LRZ, MJ | Right ATL |
| 53 | F | 51 | Epilepsy | LSC, CLB | Left ATL |
| 44 | F | 3 | Epilepsy | LTG | Left ATL |
| 25 | M | 14 | Epilepsy | CBZ | Right ATL |
| 19 | F | 15 | Epilepsy | PB, CLB, GPN, RFM | Right ATL |
| 30 | M | 12 | Epilepsy | PHN | Left ATL |
| 26 | M | 5 | Epilepsy | CBZ, DR | Right ATL |
| 28 | M | 13 | Epilepsy | CLB, MJ | Left ATL |
| 52 | F | 6 | Epilepsy | LTG, LEF | Left ATL |
| 26 | F | 9 | Epilepsy | ESL, TMP, CLB | Right ATL |
| 59 | F | 39 | Epilepsy | CLB, LSC | Right ATL |
| 37 | M | 5 | Epilepsy | CLB, LSC | Right ATL |
| 55 | M | 27 | Epilepsy | CLB, ESL, LTG | Left ATL |
| 42 | F | 3 | Epilepsy | CBZ, GPN | Right-ATL |
| 57 | F | 56 | Epilepsy | CLB, LTG, PRM, CBD oil | Left ATL |
| 24 | M | 4 | Epilepsy | LEV, LTG | Left ATL |
| 33 | M | 6 | Epilepsy | LSC, PGBPHN | Right ATL |
| 39 | M | 12 | Epilepsy | CLB, LTG, MJ | Left ATL |
| 36 | F | 16 | Epilepsy | LSC, PGB, PHN | Right ATL |
CBZ Carbamazepine, CLB Clobazam, CZP Clonazepam, DR Divalproex, GPN Gabapentin, LEV Levetiracetam, LRZ Lorazepam, LSC Lacosamide, LTG Lamotrigine, MJ Marijuana, PB Phenobarbital, PHN Phenytoin, RFM Rufinamide, LEF Leflunomide, ESL Eslicarbazepine acetate, TMP Tetramethylpyrazine, PRM primidone, CBD cannabidiol, PGB Pregabalin, FL frontal lobe.